Outcomes: Primary criterion
8+/−2
The primary criterion is the rate of patients Normal whole body scan (SPECT-CT) at the time of administration of Normal neck ultrasound at 8+/−2 months after Unstimultaed ultrasensitive thyroglobuline while on L-thyroxine treatment (usTg/LT4) ≤ 0.2 ng/mL without anti-Tg antibodies (TgAb) at 8+/−2 months after 